Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Appropriate VTE prophylaxis is associated with lower direct medical costs.

Amin A, Hussein M, Battleman D, Lin J, Stemkowski S, Merli GJ.

Hosp Pract (1995). 2010 Nov;38(4):130-7. doi: 10.3810/hp.2010.11.350.

PMID:
21068537
2.

Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.

Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D.

Adv Ther. 2010 Sep;27(9):623-33. doi: 10.1007/s12325-010-0056-z. Epub 2010 Jul 30.

PMID:
20680533
3.

Propensity score matching in the evaluation of drug therapy management programs: an illustrative analysis of a program for patients with hepatitis C virus.

Hussein M, Benner JS, Lee D, Sesti AM, Battleman DS, Brock-Wood C.

Qual Manag Health Care. 2010 Jan-Mar;19(1):25-33. doi: 10.1097/QMH.0b013e3181ccbc7a.

PMID:
20042931
4.

Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation.

Kim MH, Klingman D, Lin J, Battleman DS.

Pharmacotherapy. 2009 Dec;29(12):1417-26. doi: 10.1592/phco.29.12.1417.

PMID:
19947801
5.

Rates of venous thromboembolism occurrence in medical patients among the insured population.

Spyropoulos AC, Hussein M, Lin J, Battleman D.

Thromb Haemost. 2009 Nov;102(5):951-7. doi: 10.1160/TH09-02-0073.

PMID:
19888534
6.

Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy.

Kim MH, Lin J, Hussein M, Battleman D.

Curr Med Res Opin. 2009 Dec;25(12):3037-47. doi: 10.1185/03007990903368716.

PMID:
19852699
7.

Hospital-based costs associated with venous thromboembolism prophylaxis regimens.

Merli G, Ferrufino CP, Lin J, Hussein M, Battleman D.

J Thromb Thrombolysis. 2010 May;29(4):449-58. doi: 10.1007/s11239-009-0371-x.

PMID:
19847624
8.

Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?

Deitelzweig SB, Lin J, Hussein M, Battleman D.

J Thromb Thrombolysis. 2010 Jul;30(1):55-66. doi: 10.1007/s11239-009-0393-4.

PMID:
19795190
9.

Cost of atrial fibrillation in United States managed care organizations.

Kim MH, Lin J, Hussein M, Kreilick C, Battleman D.

Adv Ther. 2009 Sep;26(9):847-57. doi: 10.1007/s12325-009-0066-x. Epub 2009 Sep 19.

PMID:
19768638
10.

Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study.

Spyropoulos AC, Hussein M, Lin J, Battleman D.

J Thromb Thrombolysis. 2009 Nov;28(4):458-64. doi: 10.1007/s11239-009-0351-1.

PMID:
19479199
11.

Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.

Kim MH, Klingman D, Lin J, Pathak P, Battleman DS.

Ann Pharmacother. 2009 May;43(5):840-8. doi: 10.1345/aph.1L698.

PMID:
19417111
12.

Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation.

Kim MH, Lin J, Hussein M, Battleman D.

Curr Med Res Opin. 2009 May;25(5):1215-20. doi: 10.1185/03007990902869235 .

PMID:
19327101
13.

Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series.

Wolf J, Richardson PG, Schuster M, LeBlanc A, Walters IB, Battleman DS.

Clin Adv Hematol Oncol. 2008 Oct;6(10):755-60.

PMID:
18997666
14.

Hospital-based costs associated with venous thromboembolism treatment regimens.

Merli G, Ferrufino C, Lin J, Hussein M, Battleman D.

J Thromb Haemost. 2008 Jul;6(7):1077-86. doi: 10.1111/j.1538-7836.2008.02997.x. Epub 2008 Jul 1.

15.

Therapeutic goal attainment in patients with hypertension and dyslipidemia.

Johnson ML, Pietz K, Battleman DS, Beyth RJ.

Med Care. 2006 Jan;44(1):39-46.

PMID:
16365611
16.

Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications.

Petrilla AA, Benner JS, Battleman DS, Tierce JC, Hazard EH.

Int J Clin Pract. 2005 Dec;59(12):1441-51. Review.

PMID:
16351677
17.

Predictors of adherence with antihypertensive and lipid-lowering therapy.

Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS.

Arch Intern Med. 2005 May 23;165(10):1147-52.

PMID:
15911728
18.

Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.

Johnson ML, Pietz K, Battleman DS, Beyth RJ.

Am J Manag Care. 2004 Dec;10(12):926-32.

19.

Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens.

Bisognano J, McLaughlin T, Roberts CS, Battleman D, Schwartz B, Garza D, Tang S.

Am J Hypertens. 2004 Aug;17(8):676-83.

PMID:
15323063
20.

Economic consequences of renal dysfunction among cardiopulmonary bypass surgery patients: a hospital-based perspective.

Callahan M, Battleman DS, Christos P, Efimba M, Whitelaw G.

Value Health. 2003 Mar-Apr;6(2):137-43.

22.

Multidisciplinary approach to improving treatment of community-acquired pneumonia.

Cregin R, Segal-Maurer S, Weinbaum F, Rahal J, Kabrowitz S, Sixsmith D, Cassata V, Danek M, Battleman D, Callahan M.

Am J Health Syst Pharm. 2002 Feb 15;59(4):364-8. No abstract available.

PMID:
11885401
23.

A practice-profiling system for residents.

Callahan M, Fein O, Battleman D.

Acad Med. 2002 Jan;77(1):34-9.

PMID:
11788320
24.

Dedicated asthma center improves the quality of care and resource utilization for pediatric asthma: a multicenter study.

Battleman DS, Callahan MA, Silber S, Muñoz CI, Santiago L, Abularrage J, Jabbar H.

Acad Emerg Med. 2001 Jul;8(7):709-15.

25.

Gender differences in utilization of exercise treadmill testing: a claims-based analysis.

Battleman DS, Callahan M.

J Healthc Qual. 2001 May-Jun;23(3):38-41.

PMID:
11378976
26.

Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients.

Altmann DB, Racz M, Battleman DS, Bergman G, Spokojny A, Hannan EL, Sanborn TA.

Am Heart J. 1996 Sep;132(3):503-7.

PMID:
8800018
27.

Intracoronary stents.

Jauhar R, Battleman DS, Altmann DB, Parikh M, Flyer J, Autz L, Sanborn TA.

Surg Technol Int. 1996;5:283-9.

PMID:
15858753
28.

Mechanism of repetitive monomorphic ventricular tachycardia.

Lerman BB, Stein K, Engelstein ED, Battleman DS, Lippman N, Bei D, Catanzaro D.

Circulation. 1995 Aug 1;92(3):421-9.

PMID:
7634458
29.
30.

Receptors for nerve growth factor.

Chao MV, Battleman DS, Benedetti M.

Int Rev Cytol. 1992;137B:169-80. Review. No abstract available.

PMID:
1478819

Supplemental Content

Loading ...
Support Center